- Home
- BFRI
BFRI
Biofrontera Inc.
as 07-26-2024 4:00pm EST
Biofrontera Inc is a United States-based biopharmaceutical company commercializing a portfolio of pharmaceutical products for the treatment of dermatological conditions with a focus on photodynamic therapy (PDT) and topical antibiotics. Its licensed products are used for the treatment of actinic keratoses, which are pre-cancerous skin lesions, as well as impetigo, a bacterial skin infection. Its licensed product is Ameluz, which is a prescription drug approved for use in combination with the RhodoLED lamp series, for PDT (when used together, Ameluz PDT). including the complementary product BF-RhodoLED, and Xepi.
| Founded: | 1997 | Country: | United States |
| Employees: | N/A | City: | WOBURN |
| Market Cap: | 4.6M | IPO Year: | 2021 |
| Target Price: | $18.00 | AVG Volume (30 days): | 52.8K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 1 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -10.20 | EPS Growth: | N/A |
| 52 Week Low/High: | $0.61 - $12.50 | Next Earning Date: | 08-09-2024 |
| Revenue: | $33,252,000 | Revenue Growth: | 20.23% |
| Revenue Growth (this year): | 18.52% | Revenue Growth (next year): | 25.58% |
Latest Biofrontera Inc. News
BFRI Breaking Stock News: Dive into BFRI Ticker-Specific Updates for Smart Investing
Simply Wall St.
15 days ago
When Will Biofrontera Inc. (NASDAQ:BFRI) Become Profitable?
GlobeNewswire
a month ago
Biofrontera Announces the Launch of a New, FDA-Approved Red Light Source, the RhodoLED® XL Lamp
ACCESSWIRE
2 months ago
Biofrontera Inc. Reports First Quarter 2024 Financial Results and Provides a Business Update
ACCESSWIRE
3 months ago
Biofrontera Inc. to Report First Quarter 2024 Financial Results on May 15, 2024
ACCESSWIRE
3 months ago
Biofrontera Announces Achievement of Two Milestones Associated with Series B-3 Convertible Preferred Stock Warrants
ACCESSWIRE
4 months ago
Biofrontera Inc. Announces 2024 Annual Meeting of Stockholders and Deadlines for Submission of Stockholder Proposals
Insider Monkey
4 months ago
Biofrontera Inc. (NASDAQ:BFRI) Q4 2023 Earnings Call Transcript
Thomson Reuters StreetEvents
4 months ago
Q4 2023 Biofrontera Inc Earnings Call
Compare BFRI vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "BFRI Biofrontera Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.